• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

BON:GR

61.480 EUR 0.510 0.82%

As of 07:41:36 ET on 07/25/2014.

Snapshot for Boiron SA (BON)

Open: 61.650 Day's Range: 61.260 - 61.990 Volume: 150
Previous Close: 61.990 52wk Range: 38.715 - 67.910 1-Yr Rtn: +53.36%

Stock Chart for BON

No chart data available.
  • BON:GR 61.480
  • 1D
  • 1M
  • 1Y
61.990
Interactive BON Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BON

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 15.8331
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 3.8830
Est. PEG Ratio -
Market Cap (M EUR) 1,195.28
Shares Outstanding (M) 19.44
30 Day Average Volume 34
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.96%
Cash Dividend (EUR) 1.2000
Dividend Ex-Date 06/03/2014
5 Year Dividend Growth 14.87%
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BON

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BON

Boiron SA researches, develops, and manufactures homeopathic pharmaceutical products. The Company operates worldwide either directly through subsidiaries and sales offices, or through local distributors. The main industrial and commercial facilities are located in France, elsewhere in Western Europe, and North America.

Thierry BoironChairmanChristian BoironChief Executive Officer
Phillippe GouretCo-COOValerie PoinsotCo-COO
More Company Profile & Key Executives for BON

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil